GC Aesthetics Publishes Results of Eight Year Clinical Study

Eurosilicone Breast Implants Demonstrate Exceptional Safety Rates

LONDON--()--Breast Augmentation is the most popular cosmetic surgery treatment in the world. As the number of augmentations continue to rise, safety has never been more important.

With a strong commitment to setting the ‘Gold Standard’ in care, quality and safety for patients and surgeons alike, GC Aesthetics, a global leader in the medical aesthetics space, is conducting a 10 year long-term clinical study into the safety of the implants expertly produced by one of their brands, Eurosilicone.

This is the eight-year interim results update of this ten-year prospective clinical study which reviewed the safety and performance of Eurosilicone’s breast implants at 17 private and university hospitals in France. In total, 526 women were involved in the study, in a total of 995 implants. This study was recently published in the Aesthetic Surgery Journal.

Eurosilicone’s results demonstrated a very high safety rate. With a rupture rate of less than 2% and a reoperation rate of 3.6%, the findings were shown to be lower than the nine-year study reported by other breast implant manufacturers.

Ayse Kocak, CEO of GC Aesthetics comments, “As a global leader in the breast implant space, GC Aesthetics is committed to defining and upholding the ‘Gold Standard’ when it comes to safety, care and quality. I believe this study is the largest prospective study of breast implants in Europe.

We thrive on delivering the best possible products, and the results of the eight-year study further demonstrate our very high safety rate which should give our surgeons and their patients further peace of mind.

“Whilst we are delighted to see these results, we will continue to use these findings to help further enhance our services and products to ensure we offer the very best to both surgeons and patients.”

www.gcaesthetics.com

About GC Aesthetics

GC Aesthetics is a leading medical aesthetics company committed to becoming the trusted brand and partner for women who want to look healthy, youthful, vibrant and beautiful.

Through the two leading brands – Nagor and Eurosilicone, GC Aesthetics has 30 years of experience in breast implants.

In 2017, GC Aesthetics became the global leader in breast implants in key markets. With this impressive accolade under the brand’s belt, GC Aesthetics continues to set the ‘Gold Standard’ when it comes to innovation, quality, safety and care within the sector.

Contacts

For GC Aesthetics:
Natalie Willey, 020 3745 6960
natalie.willey@edencancan.com

Release Summary

GC Aesthetics is conducting a 10 year long-term clinical study into the safety of the implants expertly produced by one of their brands, Eurosilicone

Contacts

For GC Aesthetics:
Natalie Willey, 020 3745 6960
natalie.willey@edencancan.com